VeriMoms-silkworm oligopeptide-1 sp est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification nor SCCS/CIR safety flags found for oligopeptide-1 or silk-derived peptides. Peer-reviewed literature on topical EGF/oligopeptides indicates local skin activity with minimal systemic exposure, and no evidence of reproductive toxicity in the cosmetic safety literature (CIR/SCCS absent). Therefore default hazard/mechanism scores are 0 and estimated exposure from topical use is negligible (e=0). Sources: CIR (no assessment indicating repro hazard), SCCS absence, PubMed literature on topical EGF safety, CosIng/PubChem listings.
Related ingredients
Frequently asked questions
- s-silkworm oligopeptide-1 sp est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification nor SCCS/CIR safety flags found for oligopeptide-1 or silk-derived peptides. Peer-reviewed literature on topical EGF/oligopeptides indicates local skin activity with minimal systemic exposure, and no evidence of reproductive toxicity in the cosmetic safety literature (CIR/SCCS absent). Therefore default hazard/mechanism scores are 0 and estimated exposure from topical use is negligible (e=0). Sources: CIR (no assessment indicating repro hazard), SCCS absence, PubMed literature on topical EGF safety, CosIng/PubChem listings.
- s-silkworm oligopeptide-1 sp est-il sûr pendant l'allaitement ?
- No evidence of breastmilk transfer or systemic reproductive/breastfeeding-specific toxicity for silk-derived oligopeptides; peptides applied topically generally show low systemic bioavailability, so risk to nursing infants is not indicated. Sources: PubMed on topical peptide absorption, CosIng/PubChem entries; no regulatory flags (ECHA Annex VI/CIR).
- s-silkworm oligopeptide-1 sp est-il sûr pour la peau de bébé ?
- Hazard and mechanism remain 0 (no data indicating reproductive/developmental toxicity). Exposure increased by one level for infants because immature skin barrier and higher surface-area-to-weight can increase systemic uptake; while adult dermal absorption is expected negligible, baby exposure is considered low but measurable (e=1). No infant-specific toxicity data found. Sources: general dermal absorption principles in peer-reviewed literature; regulatory databases (CosIng, PubChem); absence of adverse classifications (ECHA Annex VI/CIR).
- Comment VeriMom évalue-t-il s-silkworm oligopeptide-1 sp ?
- VeriMom évalue s-silkworm oligopeptide-1 sp à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à s-silkworm oligopeptide-1 sp pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à s-silkworm oligopeptide-1 sp basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.